Blinatumomab for minimal residual disease in adults with B-precursor acute lymphoblastic leukemia.

Item

http://www.wikidata.org/entity/Q48191947

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Blinatumomab for minimal resid ...... acute lymphoblastic leukemia.

@en

Blinatumomab for minimal resid ...... acute lymphoblastic leukemia.

@nl

type

Item

label

Blinatumomab for minimal resid ...... acute lymphoblastic leukemia.

@en

Blinatumomab for minimal resid ...... acute lymphoblastic leukemia.

@nl

prefLabel

Blinatumomab for minimal resid ...... acute lymphoblastic leukemia.

@en

Blinatumomab for minimal resid ...... acute lymphoblastic leukemia.

@nl

P1476

Blinatumomab for minimal resid ...... acute lymphoblastic leukemia.

@en

P2093

Christoph Faul

http://www.w3.org/2001/XMLSchema#string

Dirk Nagorsen

http://www.w3.org/2001/XMLSchema#string

Gerhard Zugmaier

http://www.w3.org/2001/XMLSchema#string

Heinz-August Horst

http://www.w3.org/2001/XMLSchema#string

Hendrik Wessels

http://www.w3.org/2001/XMLSchema#string

Julia Stieglmaier

http://www.w3.org/2001/XMLSchema#string

Max S Topp

http://www.w3.org/2001/XMLSchema#string

Nicola Gökbuget

http://www.w3.org/2001/XMLSchema#string

Vincent Haddad

http://www.w3.org/2001/XMLSchema#string

Violaine Havelange

http://www.w3.org/2001/XMLSchema#string

P2860

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

Chimeric antigen receptor T cells for sustained remissions in leukemia

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials.

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.

P304

1522-1531

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2017-08-798322

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

Albrecht Reichle

Monika Brüggemann

Massimiliano Bonifacio

P577

2018-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29358182

http://www.w3.org/2001/XMLSchema#string

P932

6027091

http://www.w3.org/2001/XMLSchema#string